Gilead gets WHO cold shoulder for remdesivir in COVID-19 ...

FiercePharma - 12 Dec 2021
Gilead Sciences' Veklury, better known as remdesivir, is so far the only COVID-19 therapy officially approved by the FDA, but the World Health Organization has ...

Real life experience on the use of Remdesivir in patients admitted to COVID-19 in two referral Italian hospital: a ...

Nature.com - 23 Apr 2024
Real life experience on the use of Remdesivir in patients admitted to COVID-19 in two referral Italian hospital: a ... ...

Remdesivir tied to 25% lower risk of in-hospital death in adults with COVID and no added oxygen

University of Minnesota Twin Cities - 17 Apr 2024
Remdesivir tied to 25% lower risk of in-hospital death in adults with COVID and no added oxygen ...

COVID-19 Treatments: What We Know So Far > News

Yale Medicine - 26 May 2023
COVID-19 Treatments: What We Know So Far > News ...

Comparable outcomes of outpatient remdesivir and sotrovimab among high-risk patients with mild to moderate COVID ...

Nature.com - 05 Mar 2024
Comparable outcomes of outpatient remdesivir and sotrovimab among high-risk patients with mild to moderate COVID ... ...

Information about outpatient COVID-19 therapeutics for health care providers | Department of Public Health ...

Colorado Department of Public Health and Environment - 18 Jan 2024
Information about outpatient COVID-19 therapeutics for health care providers | Department of Public Health ... ...

Two cases show COVID virus mutating around standard treatment remdesivir

Medical Xpress - 23 Jan 2024
Two cases show COVID virus mutating around standard treatment remdesivir ...

COVID-19 Mortality and Remdesivir – A Retrospective Cohort in Intensive Care Setting

Cureus - 23 Dec 2023
COVID-19 Mortality and Remdesivir – A Retrospective Cohort in Intensive Care Setting ...

Safety of Remdesivir in Patients With Reduced Renal Function

DocWire News - 05 Feb 2024
Safety of Remdesivir in Patients With Reduced Renal Function ...

Pulmonary delivery of remdesivir and dexamethasone encapsulated nanostructured lipid carriers for enhanced ...

ScienceDirect.com - 04 Nov 2023
Pulmonary delivery of remdesivir and dexamethasone encapsulated nanostructured lipid carriers for enhanced ... ...

Michigan judge denies drug manufacturer's immunity in case of contaminated COVID-19 medication

WWMT-TV - 08 Aug 2023
Michigan judge denies drug manufacturer's immunity in case of contaminated COVID-19 medication ...

Gilead Sued In Calif. Over Remdesivir COVID-19 Claims

Law360 - 07 Dec 2023
Gilead Sued In Calif. Over Remdesivir COVID-19 Claims ...

FDA Approves First Treatment for COVID-19

FDA.gov - 22 Oct 2020
FDA Approves First Treatment for COVID-19 ...

New Real-World Data Further Support the Use of Veklury® (Remdesivir) for People Hospitalized With COVID-19

Business Wire - 05 Mar 2024
New Real-World Data Further Support the Use of Veklury® (Remdesivir) for People Hospitalized With COVID-19 ...

Remdesivir tied to lower COVID death rates in hospital patients receiving oxygen

University of Minnesota Twin Cities - 22 Sep 2023
Remdesivir tied to lower COVID death rates in hospital patients receiving oxygen ...

Final report confirms remdesivir benefits for COVID-19

National Institutes of Health (NIH) (.gov) - 20 Oct 2020
Final report confirms remdesivir benefits for COVID-19 ...

Concentrations of remdesivir and GS-441524 in human milk from lactating individuals diagnosed with COVID-19 ...

Nature.com - 12 Feb 2024
Concentrations of remdesivir and GS-441524 in human milk from lactating individuals diagnosed with COVID-19 ... ...

NIH clinical trial of remdesivir to treat COVID-19 begins

National Institutes of Health (NIH) (.gov) - 25 Feb 2020
NIH clinical trial of remdesivir to treat COVID-19 begins ...

Remdesivir tied to lower death rates in COVID hospital patients with weakened immune systems

University of Minnesota Twin Cities - 10 Aug 2023
Remdesivir tied to lower death rates in COVID hospital patients with weakened immune systems ...

Remdesivir increases mtDNA copy number causing mild alterations to oxidative phosphorylation | Scientific Reports

Nature.com - 15 Sep 2023
Remdesivir increases mtDNA copy number causing mild alterations to oxidative phosphorylation | Scientific Reports ...

Remdesivir